Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia

NCT01377233 ·Status: COMPLETED ·Phase: PHASE2

Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo

NCT00570063 ·Status: TERMINATED ·Phase: PHASE2

Safety, Blood Levels and Effects of AUT00206

NCT02589262 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.

NCT03164876 ·Status: COMPLETED ·Phase: PHASE1

SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia

NCT01234298 ·Status: WITHDRAWN ·Phase: PHASE3

Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

NCT00086593 ·Status: COMPLETED ·Phase: PHASE3

A Trial to Assess the Antipsychotic Efficacy of ITI-007

NCT02282761 ·Status: COMPLETED ·Phase: PHASE3

First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

NCT01568203 ·Status: TERMINATED ·Phase: PHASE1

A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia

NCT01812642 ·Status: COMPLETED ·Phase: PHASE2

A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia

NCT02205099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder

NCT02006628 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

NCT02832037 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia

NCT05545111 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Multiple Ascending Dose in Schizophrenia Patients

NCT00620568 ·Status: TERMINATED ·Phase: PHASE1

Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)

NCT00156065 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)

NCT00156104 ·Status: COMPLETED ·Phase: PHASE3

Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

NCT00207064 ·Status: COMPLETED ·Phase: NA

A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia

NCT04510298 ·Status: COMPLETED ·Phase: PHASE1

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

NCT05958875 ·Status: RECRUITING ·Phase: PHASE4

Add-on Simvastatin in Schizophrenia Trial

NCT00605995 ·Status: TERMINATED ·Phase: NA

Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia

NCT00063297 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics

NCT02037074 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

NCT07145918 ·Status: RECRUITING ·Phase: PHASE2

Study of CAD-9303 in Subjects With Schizophrenia

NCT04306146 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

NCT01160679 ·Status: COMPLETED